JONATHAN PARKER: Open Payments
NPI 1710272265 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,093 in 55 payments from 13 companies in 2025. Trend: 2023 $8,978 · 2024 $31,670 · 2025 $16,093
Speaker / faculty: $15,014Food & beverage: $1,034Travel & lodging: $46
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $15,704 |
| Corcept Therapeutics | 8 | $154 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| ABBVIE INC. | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Antares Pharma, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
Products named: Wegovy, Ozempic, Korlym, VRAYLAR, NURTEC ODT, XYOSTED, TRINTELLIX, BREZTRI.
Industry payments across AL — which companies pay providers there.
